FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

FDA Approves Two Bayer Products to Help MS Patients Stay on Top of Interferon Injections















The U.S. Food and Drug Administration has approved a supplemental biologics license application for two Bayer products that help multiple sclerosis patients keep track of their injections of Betaseron (interferon beta-1b).

The products are the myBETAapp and the Betaconnect Navigator software. A biologics license application is a request for permission to market a biologic product.

Patients with relapsing-remitting MS (RRMS) can use the electronic Betaconnect auto-injector to administer Betaseron, a prescription medicine that reduces MS relapses.

Betaconnect Navigator allows patients to use Bluetooth technology to connect their auto-injector to a myBETAapp on their cellphone or laptop. That connection allows patients to share their injection information with their BETA Nurse and healthcare team. A BETA Nurse is a person trained in MS support whom Betaseron makes available 24/7 by phone to patients who have questions.

Having injection information on the cloud lets healthcare providers see patients’ injection history, and may help them develop better support strategies for those taking Betaseron.

“Since introducing the first FDA-approved treatment option for relapsing remitting multiple sclerosis patients more than two decades ago, we’ve listened closely to the community to understand their needs and how we can support them,” Mark Rametta, Bayer’s medical director of neurology, said in a press release.

“The myBETAapp and Betaconnect Navigator add to the services that we’ve developed based on patient feedback, including 24/7 access to nurse support and the first and only electronic autoinjector for patients taking Betaseron,” Rametta added.

The Betaconnect auto-injector, myBETAapp and the Betaconnect Navigator were developed by Denmark-based Medicom Innovation Partner.

Bayer expects the myBETAapp to be available for free download on app stores in mid-July. Patients who are enrolled in Betaplus – Bayer’s patient support program – can speak directly to a Beta Nurse.

“The myBETAapp and Betaconnect Navigator work cohesively together to support communication and connection between people living with relapsing remitting multiple sclerosis and their Beta Nurse and health care team,” said Daniel Kantor, president emeritus of the Florida Society of Neurology.

Patients using other injection methods to take Betaseron can manually enter injection information into the myBETAapp to share with their healthcare team.

Patients who should not take Betaseron include those allergic to interferon beta-1b, other interferon betas, human albumin or mannitol.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News